West Pharmaceutical Services share price logo

West Pharmaceutical Services

NYSE: WST

Large Cap

$372.53

-3.12

(-0.83%)

Live

as on

West Pharmaceutical Services Stock Performance

as on September 30, 2026 at 2:12 am IST

  • Day's Low

    Day's High

    $370.80
    $377.76
    downward going graph

    0.46%

    Downside

    1.40%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $223.83
    $386.00
    downward going graph

    39.92%

    Downside

    3.62%

    Upside

    downward going graph

West Pharmaceutical Services share price movements today

Previous Close
$375.65
Open
$375.51
Volume
104.8K
Market Cap
$26.1B
Dividend Yield
0.24%
Day's Low - High
$370.80 - $377.76
52 Week Low - High
$223.83 - $386.00

West Pharmaceutical Services Historical Returns

1 Month Return
+ 11.31 %
3 Month Return
+ 5.91 %
1 Year Return
+ 44.3 %
3 Year Return
+ 0.12 %
5 Year Return
-13.13 %

West Pharmaceutical Services Stock Fundamentals & Key Indicators

Check West Pharmaceutical Services market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.1B

EPS (TTM)

7.87

Dividend Yield

0.24%

Quarterly Earnings Growth YOY

0.18%

PE Ratio (TTM)

47.05

Industry PE ratio

24.14

PEG Ratio

2.7494047842660634

EBITDA

824.2M

Revenue (TTM)

3.3B

Profit Margin

36.77%

Return On Equity TTM

18.51%

West Pharmaceutical Services Stock Valuation

Track how West Pharmaceutical Services P/E has moved over time to understand its valuation trends.

West Pharmaceutical Services in the last 5 years

  • Overview

  • Trends

Lowest (29.89x)

December 31, 2022

Industry (24.14x)

December 31, 2025

Today (40.28x)

December 31, 2025

Highest (52.73x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 40.28x

West Pharmaceutical Services vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of West Pharmaceutical Services with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$26.1B-13.13%47.0536.77%0.24%
Neutral$32.0B-16.3%21.2661.16%1.11%
StrongBuy$145.2B25.4%45.7866.68%0.00%
Buy$50.1B-26.99%55.3746.12%2.16%
StrongBuy$46.7BNA40.3525.02%0.00%

Stock Returns calculator for West Pharmaceutical Services Stock including INR - Dollar returns

The West Pharmaceutical Services stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

West Pharmaceutical Services investment value today

Current value as on today

₹1,54,843

Returns

₹54,843

(+54.84%)

Returns from West Pharmaceutical Services Stock

₹43,105 (+43.1%)

Dollar Impact

₹11,738 (+11.74%)

Analyst Recommendation on West Pharmaceutical Services Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for West Pharmaceutical Services. Average target price of $407.56

West Pharmaceutical Services Share Price Target

Get share price movements and forecasts by analysts on West Pharmaceutical Services.

What analysts predicted

8.6%UPSIDE

Target Price

$407.56

Current Price

$372.53

Analyzed by

8 Analysts

High

$425

Target

$407.56

Low

$390

West Pharmaceutical Services target price $407.56, a slight upside of 8.6% compared to current price of $372.53. According to 8 analysts rating.

Indian Investors' Interest in West Pharmaceutical Services Stock

Search interest for West Pharmaceutical Services Stock has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-73% versus previous 30 day period

West Pharmaceutical Services Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
695
702
746
748
698
766
804
805
844
872
Gross Profit
231
231
265
274
232
273
293
303
296
329
Operating Income
127
130
167
170
128
158
173
156
177
179
EBITDA
164
169
205
205
150
198
217
209
218
179
Interest Expense
1
1
0
-
0
0
0
-
-
-
Depreciation
35
38
40
40
40
41
43
47
44
-
Income Before Tax
131
133
168
166
113
162
174
165
180
180
Income Tax Expense
16
21
32
36
24
30
34
33
44
32
Net Income
115
111
136
130
89
131
140
132
138
154
Net Profit Margin
33.27%
32.95%
35.51%
36.66%
33.33%
35.66%
36.49%
37.75%
35.08%
37.74%

West Pharmaceutical Services Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,600
1,718
1,843
2,146
2,830
2,885
2,951
2,892
3,073
Gross Profit
514
546
608
767
1,173
1,138
1,132
1,002
1,103
Operating Income
229
254
297
419
758
763
710
594
617
EBITDA
326
353
403
518
879
808
844
743
723
Interest Expense
7
8
8
8
8
7
8
2
0
Depreciation
96
104
103
109
122
120
137
155
124
Income Before Tax
231
248
300
418
769
700
715
600
615
Income Tax Expense
80
41
59
72
107
114
122
107
121
Net Income
150
206
241
346
661
585
593
492
493
Net Profit Margin
32.17%
31.80%
33.02%
35.77%
41.45%
39.47%
38.38%
34.65%
35.89%

West Pharmaceutical Services Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
115
111
136
130
89
131
140
132
138
154
Operating Cash Flow
118
165
180
190
129
177
197
251
89
124
Investing Cash Flow
-90
-101
-82
-104
-71
-75
-63
-76
-42
-43
Financing Cash Flow
-271
-218
-64
-68
-147
-14
-11
-11
-308
-164
Change in Cash
-252
-155
44
-6
-80
105
118
162
-269
-85

West Pharmaceutical Services Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
150
206
241
346
661
585
593
492
493
Operating Cash Flow
263
288
367
472
584
724
776
653
754
Investing Cash Flow
-133
-100
-228
-179
-253
-288
-368
-378
-285
Financing Cash Flow
-109
-80
-36
-137
-168
-293
-459
-622
-185
Change in Cash
32
101
101
176
147
131
-40
-369
306

Mutual Funds that own West Pharmaceutical Services Stock

Check out the Mutual Funds with significant holdings in West Pharmaceutical Services.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
10.359102%
7290297
Fidelity Concord Street Trust
1.738904%
1223767
T. ROWE PRICE MID-CAP GROWTH FUND, INC.
1.507195%
1060700
SIX CIRCLES TRUST
1.129278%
794738
AMCAP Fund
0.809777%
569887

Global Institutional Holdings in West Pharmaceutical Services

Funds
Holdings
Vanguard
11.75%
VANGUARD INDEX FUNDS
10.36%
iShares
5.56%
SPDR
4.1%
David Blood
2.88%

West Pharmaceutical Services News & Key Events

  • img

    Today's Timeline - 10 September

    Thu, 10:27 PM

    -

    West Pharmaceutical reported Q2 2026 adjusted EPS of $2.37, beating estimates by 13.9% and revenues of $872.3 million surpassing estimates by 4.2%.

    Fri, 01:10 AM

    -

    West Pharmaceutical's CEO received stock options and RSUs with multi-year vesting, enhancing long-term incentives.

    Fri, 03:10 AM

    -

    Annette F. Favorite, Sr. VP & Chief HR Officer, sold shares worth over $2.7M, retaining 16,844 shares.

Insights on West Pharmaceutical Services

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 698.20M → 872.29M (in $), with an average increase of 4.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WST has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 132.10M → 153.99M (in $), with an average increase of 7.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WST has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, WST stock has moved up by 11.3%

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
OrganisationWest Pharmaceutical Services
Headquarters530 Herman O. West Drive, Exton, PA, 19341-1147, US
IndustryMedical - Instruments & Supplies
CEOMichel Lagarde
E-voting on sharesClick here to vote

Key Management of West Pharmaceutical Services

Name

Title

Ms. Annette F. Favorite

Chief HR Officer & Senior VP

Mr. John P. Sweeney C.F.A.

Vice President of Investor Relations

Mr. Norman D. Finch Jr.

Senior VP, General Counsel & Corporate Secretary

Ms. Michele Polinsky

Vice President of Global Communications

Mr. Robert W. McMahon C.M.A.

Senior VP & CFO

Mr. Shane A. Campbell

SVP & Chief Proprietary Segment Officer

Mr. Michel Lagarde

President, CEO & Director

Mr. Chad R. Winters

VP of Finance & Chief Accounting Officer

Dr. Devesh Mathur

Senior VP & CTO

Mr. Rudy J. Poussot

Senior Vice President of Strategy & Corporate Development

FAQs

What is West Pharmaceutical Services share price today?

West Pharmaceutical Services share price today is $372.53 as on . West Pharmaceutical Services share today touched a day high of $377.76 and a low of $370.80.

What is the 52 week high and 52 week low for West Pharmaceutical Services share?

West Pharmaceutical Services share touched a 52 week high of $386.00 on and a 52 week low of $223.83 on . West Pharmaceutical Services stock price today i.e. is trending at $372.53,which is 3.49% down from its 52 week high and 66.43% up from its 52 week low.

What is West Pharmaceutical Services's market capitalisation today?

West Pharmaceutical Services market capitalisation is $0.03T as on .

How to invest in West Pharmaceutical Services Stock (WST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for West Pharmaceutical Services on INDmoney app. Click on Buy button. You can invest as low as $1.5 in West Pharmaceutical Services Shares that will get you 0.0040 shares as per West Pharmaceutical Services share price of $372.53 per share as on September 29, 2026 at 8:42 pm IST.

What is the minimum amount required to buy West Pharmaceutical Services Stock (WST) from India?

Indian investors can start investing in West Pharmaceutical Services (WST) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in West Pharmaceutical Services stock (as per the Rupee-Dollar exchange rate as on ). Based on West Pharmaceutical Services share’s latest price of $372.53 as on September 29, 2026 at 8:42 pm IST, you will get 0.0268 shares of West Pharmaceutical Services. Learn more about fractional shares .

What are the returns that West Pharmaceutical Services has given to Indian investors in the last 5 years?

West Pharmaceutical Services stock has given -13.13% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?